Cathie Wood’s ARK ETF trades Shopify, Toast stock amid tech focus

Published 25/06/2025, 01:04
© Reuters.

Cathie Wood’s ARK ETFs have revealed their daily trades for Tuesday, June 24th, 2025, with notable activity in the technology sector. ARK’s most significant trades of the day included purchases of Shopify Inc (NYSE:NASDAQ:SHOP) and Toast Inc (NYSE:TOST), with Shopify leading the day’s acquisitions.

The ARKK ETF bought a combined total of 33,829 shares of Shopify across three of its funds—ARKK, ARKW, and ARKF—amounting to a substantial $3,720,513 investment. The move signals a continued bullish stance on the e-commerce platform, following a series of Shopify stock accumulations in recent days.

Toast Inc also saw a significant inflow with ARK purchasing 69,881 shares through its ARKW and ARKF ETFs, injecting an additional $3,030,040 into the restaurant-focused software company. This purchase comes on the heels of previous investments in Toast, highlighting ARK’s growing interest in the company.

ARK’s focus on the tech sector continued with the acquisition of 19,622 shares of Airbnb Inc (NASDAQ:ABNB) through its ARKK ETF, valued at $2,561,259. This follows a pattern of consistent buying of Airbnb shares over the past week, suggesting a strategic position in the travel industry disruptor.

The ARKK ETF also increased its stake in BWX Technologies Inc (NYSE:BWXT) by purchasing 9,014 shares, totaling $1,280,528. This follows a significant buy of BWX Technologies shares on Friday, indicating a strong conviction in the company’s prospects.

In the realm of genomics, ARK’s ARKK ETF bought 28,266 shares of Illumina Inc (NASDAQ:ILMN) for $2,574,113. This biotech firm has been another regular feature in ARK’s recent trades, pointing to a sustained investment in the genomics industry.

Further investments included smaller but notable buys in Beam Therapeutics Inc (NASDAQ:BEAM), CRISPR Therapeutics AG (NASDAQ:CRSP), Iridium Communications Inc (NASDAQ:IRDM), Intellia Therapeutics Inc (NASDAQ:NTLA), Twist Bioscience Corp (NASDAQ:TWST), and Veracyte Inc (NASDAQ:VCYT), with dollar values ranging from $145,935 to $1,062,016.

On the selling side, ARK’s ARKG ETF divested 9,939 shares of Adaptive Biotechnologies Corp (NASDAQ:ADPT) for $104,955, continuing a sell-off trend in the stock. Additionally, minor sales were made in Magna International Inc (NYSE:MGA) and UiPath Inc (NYSE:PATH) through the ARKQ ETF, totaling $5,608 and $5,503, respectively.

These trades reflect ARK’s ongoing strategy of investing in innovative companies, particularly within the technology and genomics sectors. Investors following Cathie Wood’s ARK ETFs will likely be watching these positions closely, especially those with increasing accumulations, to understand the long-term vision and expectations for growth.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.